vs

Side-by-side financial comparison of GCL Global Holdings Ltd (GCL) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

Oncology Institute, Inc. is the larger business by last-quarter revenue ($142.0M vs $98.7M, roughly 1.4× GCL Global Holdings Ltd). GCL Global Holdings Ltd runs the higher net margin — -5.2% vs -5.3%, a 0.1% gap on every dollar of revenue. Oncology Institute, Inc. produced more free cash flow last quarter ($2.2M vs $-5.2M).

GCL Global Holdings Ltd is a leading clean energy enterprise focusing on R&D, production and operation of photovoltaic products, energy storage systems and low-carbon energy solutions. Its main markets cover Asia, Europe, North America, serving utility, commercial and residential distributed energy users across the globe.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

GCL vs TOI — Head-to-Head

Bigger by revenue
TOI
TOI
1.4× larger
TOI
$142.0M
$98.7M
GCL
Higher net margin
GCL
GCL
0.1% more per $
GCL
-5.2%
-5.3%
TOI
More free cash flow
TOI
TOI
$7.4M more FCF
TOI
$2.2M
$-5.2M
GCL

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GCL
GCL
TOI
TOI
Revenue
$98.7M
$142.0M
Net Profit
$-5.1M
$-7.5M
Gross Margin
11.0%
Operating Margin
-6.7%
-4.9%
Net Margin
-5.2%
-5.3%
Revenue YoY
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.04
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GCL
GCL
TOI
TOI
Q4 25
$142.0M
Q3 25
$98.7M
$136.6M
Q2 25
$142.1M
$119.8M
Q1 25
$104.4M
Q4 24
$100.3M
Q3 24
$36.1M
$99.9M
Q2 24
$98.6M
Q1 24
$94.7M
Net Profit
GCL
GCL
TOI
TOI
Q4 25
$-7.5M
Q3 25
$-5.1M
$-16.5M
Q2 25
$5.6M
$-17.0M
Q1 25
$-19.6M
Q4 24
$-13.2M
Q3 24
$-1.9M
$-16.1M
Q2 24
$-15.5M
Q1 24
$-19.9M
Gross Margin
GCL
GCL
TOI
TOI
Q4 25
Q3 25
11.0%
Q2 25
15.0%
Q1 25
Q4 24
Q3 24
16.2%
Q2 24
Q1 24
Operating Margin
GCL
GCL
TOI
TOI
Q4 25
-4.9%
Q3 25
-6.7%
-5.9%
Q2 25
2.3%
-9.4%
Q1 25
-9.5%
Q4 24
-11.9%
Q3 24
-5.6%
-13.9%
Q2 24
-16.6%
Q1 24
-19.0%
Net Margin
GCL
GCL
TOI
TOI
Q4 25
-5.3%
Q3 25
-5.2%
-12.1%
Q2 25
3.9%
-14.2%
Q1 25
-18.8%
Q4 24
-13.1%
Q3 24
-5.2%
-16.1%
Q2 24
-15.7%
Q1 24
-21.0%
EPS (diluted)
GCL
GCL
TOI
TOI
Q4 25
$-0.04
Q3 25
$-0.04
$-0.14
Q2 25
$0.05
$-0.15
Q1 25
$-0.21
Q4 24
$-0.14
Q3 24
$-0.18
Q2 24
$-0.17
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GCL
GCL
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$16.6M
Total DebtLower is stronger
$52.0M
Stockholders' EquityBook value
$33.1M
$-15.7M
Total Assets
$159.9M
$164.7M
Debt / EquityLower = less leverage
1.57×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GCL
GCL
TOI
TOI
Q4 25
Q3 25
$16.6M
Q2 25
$18.2M
Q1 25
Q4 24
Q3 24
$2.7M
Q2 24
$9.9M
Q1 24
$29.8M
Total Debt
GCL
GCL
TOI
TOI
Q4 25
Q3 25
$52.0M
Q2 25
$11.9M
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GCL
GCL
TOI
TOI
Q4 25
$-15.7M
Q3 25
$33.1M
$-12.3M
Q2 25
$35.9M
$-9.0M
Q1 25
$5.1M
Q4 24
$3.6M
Q3 24
$15.9M
$15.5M
Q2 24
$29.2M
Q1 24
$41.3M
Total Assets
GCL
GCL
TOI
TOI
Q4 25
$164.7M
Q3 25
$159.9M
$163.6M
Q2 25
$101.6M
$159.8M
Q1 25
$164.0M
Q4 24
$172.7M
Q3 24
$49.6M
$179.2M
Q2 24
$179.6M
Q1 24
$204.5M
Debt / Equity
GCL
GCL
TOI
TOI
Q4 25
Q3 25
1.57×
Q2 25
0.33×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GCL
GCL
TOI
TOI
Operating Cash FlowLast quarter
$-4.8M
$3.2M
Free Cash FlowOCF − Capex
$-5.2M
$2.2M
FCF MarginFCF / Revenue
-5.3%
1.5%
Capex IntensityCapex / Revenue
0.4%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GCL
GCL
TOI
TOI
Q4 25
$3.2M
Q3 25
$-4.8M
$-12.6M
Q2 25
$-10.3M
$-10.2M
Q1 25
$-5.0M
Q4 24
$4.2M
Q3 24
$6.1M
$819.0K
Q2 24
$-15.7M
Q1 24
$-15.9M
Free Cash Flow
GCL
GCL
TOI
TOI
Q4 25
$2.2M
Q3 25
$-5.2M
$-13.2M
Q2 25
$-10.5M
$-11.4M
Q1 25
$-5.3M
Q4 24
$2.4M
Q3 24
$417.0K
Q2 24
$-17.5M
Q1 24
$-16.5M
FCF Margin
GCL
GCL
TOI
TOI
Q4 25
1.5%
Q3 25
-5.3%
-9.7%
Q2 25
-7.4%
-9.5%
Q1 25
-5.1%
Q4 24
2.4%
Q3 24
0.4%
Q2 24
-17.7%
Q1 24
-17.4%
Capex Intensity
GCL
GCL
TOI
TOI
Q4 25
0.7%
Q3 25
0.4%
0.4%
Q2 25
0.1%
1.0%
Q1 25
0.3%
Q4 24
1.8%
Q3 24
0.4%
Q2 24
1.9%
Q1 24
0.6%
Cash Conversion
GCL
GCL
TOI
TOI
Q4 25
Q3 25
Q2 25
-1.84×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GCL
GCL

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons